VAX November 2016
Vol. 14, No. 06 – November 2016
SPOTLIGHT:
- Details
- Category: VAX November 2016
The HIV Research for Prevention conference showcased advances with the potential to further decrease the rate of new infections
SPOTLIGHT:
- Details
- Category: VAX November 2016
Gerald Voss, former head of GlaxoSmithKline (GSK) Vaccine’s HIV Vaccine program and vice president of the Enterprise’s Board of Directors, is now interim director of the Global HIV Vaccine Enterprise Secretariat, replacing longtime AIDS vaccine advocate William Snow, who has stepped down.